Scott B. Ullem insider trades: Edwards Lifesciences (EW) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Scott reports to the SEC
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | EW | ↓ Sell | 13,000 | $80.04 | $1.0M | Direct | Apr 9, 2026 (0d) |
| Dec 9, 2025 | EW | ↓ Sell | 7,700 | $84.47 | $650K | Direct | Dec 9, 2025 (0d) |
| Nov 10, 2025 | EW | ↓ Sell | 13,000 | $83.08 | $1.1M | Direct | Nov 10, 2025 (0d) |
| May 9, 2025 | EW | ↓ Sell | 11,250 | $74.40 | $837K | Direct | May 9, 2025 (0d) |
| Mar 26, 2025 | EW | ↓ Sell | 11,250 | $70.87 | $797K | Direct | Mar 26, 2025 (0d) |
| Feb 28, 2025 | EW | ↓ Sell | 11,250 | $70.78 | $796K | Direct | Feb 28, 2025 (0d) |
| Feb 13, 2025 | EW | ↓ Sell | 11,250 | $75.76 | $852K | Direct | Feb 13, 2025 (0d) |
| Dec 9, 2024 | EW | ↓ Sell | 11,250 | $71.68 | $806K | Direct | Dec 9, 2024 (0d) |
| Jun 20, 2024 | EW | ↓ Sell | 5,625 | $87.51 | $492K | Direct | Jun 20, 2024 (0d) |
| May 21, 2024 | EW | ↓ Sell | 5,625 | $90.45 | $509K | Direct | May 21, 2024 (0d) |
| Apr 30, 2024 | EW | ↓ Sell | 7,250 | $85.80 | $622K | Direct | Apr 30, 2024 (0d) |
| Apr 1, 2024 | EW | ↓ Sell | 7,255 | $94.89 | $688K | Direct | Apr 1, 2024 (0d) |
| Feb 29, 2024 | EW | ↓ Sell | 7,255 | $85.59 | $621K | Direct | Feb 29, 2024 (0d) |
| Feb 1, 2024 | EW | ↓ Sell | 7,255 | $78.29 | $568K | Direct | Feb 1, 2024 (0d) |
| Dec 29, 2023 | EW | ↓ Sell | 14,510 | $76.55 | $1.1M | Direct | Dec 29, 2023 (0d) |
| Oct 31, 2023 | EW | ↓ Sell | 7,255 | $62.66 | $455K | Direct | Oct 31, 2023 (0d) |
| Sep 29, 2023 | EW | ↓ Sell | 7,255 | $69.54 | $505K | Direct | Sep 29, 2023 (0d) |
| Aug 31, 2023 | EW | ↓ Sell | 7,255 | $77.79 | $564K | Direct | Aug 31, 2023 (0d) |
| Jul 31, 2023 | EW | ↓ Sell | 7,255 | $84.35 | $612K | Direct | Jul 31, 2023 (0d) |
| Jun 30, 2023 | EW | ↓ Sell | 7,255 | $93.27 | $677K | Direct | Jun 30, 2023 (0d) |
| May 10, 2023 | EW | ↓ Sell | 80,700 | $88.54 | $7.1M | Direct | May 11, 2023 (1d) |
| Oct 26, 2020 | EW | ↓ Sell | 33,150 | $78.81 | $2.6M | Direct | Oct 26, 2020 (0d) |
| Oct 12, 2020 | EW | ↓ Sell | 33,150 | $83.81 | $2.8M | Direct | Oct 13, 2020 (1d) |
| Sep 28, 2020 | EW | ↓ Sell | 33,150 | $78.11 | $2.6M | Direct | Sep 28, 2020 (0d) |
| Sep 15, 2020 | EW | ↓ Sell | 33,150 | $83.43 | $2.8M | Direct | Sep 15, 2020 (0d) |
| Sep 14, 2020 | EW | ↓ Sell | 26,700 | $82.21 | $2.2M | Direct | Sep 14, 2020 (0d) |
| Aug 6, 2020 | EW | ↓ Sell | 26,700 | $77.31 | $2.1M | Direct | Aug 6, 2020 (0d) |
| Jul 6, 2020 | EW | ↓ Sell | 26,700 | $69.98 | $1.9M | Direct | Jul 6, 2020 (0d) |
| Jun 22, 2020 | EW | ↓ Sell | 26,700 | $69.51 | $1.9M | Direct | Jun 22, 2020 (0d) |
| Jan 7, 2020 | EW | ↓ Sell | 7,500 | $234.25 | $1.8M | Direct | Jan 7, 2020 (0d) |
| Dec 10, 2019 | EW | ↓ Sell | 7,500 | $233.88 | $1.8M | Direct | Dec 10, 2019 (0d) |
| Nov 12, 2019 | EW | ↓ Sell | 7,500 | $234.28 | $1.8M | Direct | Nov 12, 2019 (0d) |
| Oct 29, 2019 | EW | ↓ Sell | 7,500 | $235.30 | $1.8M | Direct | Oct 30, 2019 (1d) |
| Sep 9, 2019 | EW | ↓ Sell | 7,500 | $225.74 | $1.7M | Direct | Sep 9, 2019 (0d) |
| Aug 26, 2019 | EW | ↓ Sell | 7,500 | $213.44 | $1.6M | Direct | Aug 26, 2019 (0d) |
| Sep 5, 2018 | EW | ↓ Sell | 25,036 | $140.04 | $3.5M | Direct | Sep 7, 2018 (2d) |
| Aug 15, 2018 | EW | ↓ Sell | 25,000 | $136.52 | $3.4M | Direct | Aug 17, 2018 (2d) |
| Jul 3, 2018 | EW | ↓ Sell | 25,000 | $145.67 | $3.6M | Direct | Jul 6, 2018 (3d) |
| Jun 6, 2018 | EW | ↓ Sell | 25,000 | $141.07 | $3.5M | Direct | Jun 6, 2018 (0d) |
| May 9, 2018 | EW | ↓ Sell | 25,000 | $134.73 | $3.4M | Direct | May 11, 2018 (2d) |
| Apr 4, 2018 | EW | ↓ Sell | 25,000 | $137.17 | $3.4M | Direct | Apr 5, 2018 (1d) |
| Mar 28, 2018 | EW | ↓ Sell | 25,000 | $137.33 | $3.4M | Direct | Mar 30, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EW insiders
Open-market trades in the last 12 months
About Scott B. Ullem's insider trades
Scott B. Ullem is CVP, Chief Financial Officer at Edwards Lifesciences (EW). Since Mar 28, 2018, Scott has reported no open-market purchases and 42 sales worth $74.8M on SEC Form 4. In the last 12 months: 3 sales ($2.8M).
Their filings also include option exercises (57 filings), grants and awards (45 filings), shares withheld for taxes (37 filings), gifts (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EW insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.



